title: Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
authors.affiliation: American Diabetes Association.
authors.forename: Richard W
authors.initials: RW
authors.lastname: Nesto
authors.forename: David
authors.initials: D
authors.lastname: Bell
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Vivian
authors.initials: V
authors.lastname: Fonseca
authors.forename: Scott M
authors.initials: SM
authors.lastname: Grundy
authors.forename: Edward S
authors.initials: ES
authors.lastname: Horton
authors.forename: Martin
authors.initials: M
authors.lastname: Le Winter
authors.forename: Daniel
authors.initials: D
authors.lastname: Porte
authors.forename: Clay F
authors.initials: CF
authors.lastname: Semenkovich
authors.forename: Sidney
authors.initials: S
authors.lastname: Smith
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Young
authors.forename: Richard
authors.initials: R
authors.lastname: Kahn
mesh_terms: D004487:Edema / Q000139:chemically induced / Q000453:epidemiology*; D006333:Heart Failure / Q000139:chemically induced / Q000453:epidemiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D012449:Safety; D045162:Thiazolidinediones / Q000009:adverse effects*; D015430:Weight Gain
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione